PKCα and PKCβII show enhanced expression and activation in the diabetic macrovasculature [264–267], and the general PKC inhibitor bisindolylmaleimide-I blunts hyperglycemia-induced leukocyte binding to mesenteric postcapillary venules in vivo [268]. This evidence concerns the gene PRRT2 and Hyperglycemia.